Expression profile of MicroRNAs in gram-negative bacterial sepsis

Shock

Volumn 43, Issue 2, 2015, Pages 121-127

  How, Chorng Kuang ^a,b,c   Hou, Sen Kuang ^d   Shih, Hsin Chin ^b,c,e   Huang, Mu Shun ^b,c   Chiou, Shih Hwa ^a,b,c   Lee, Chen Hsen ^b,c,e   Juan, Chi Chang ^b,c,f  

^a Institute of Clinical Medicine   (India)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d Institute of Environmental and Occupational Health Sciences   (Taiwan)

^e Institute of Emergency Critical Care Medicine   (Taiwan)

^f TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

gram negative bacteria; Hsa let 7a; hsa miR 150; microarrays; toll like receptor

Indexed keywords

I KAPPA B BETA; INTERLEUKIN 1BETA; MICRORNA; MICRORNA 1249; MICRORNA 150; MICRORNA 199B 5P; MICRORNA LET 7A; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; MIRN150 MICRORNA, HUMAN; MIRNLET7 MICRORNA, HUMAN;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GRAM NEGATIVE SEPSIS; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO STUDY; INNATE IMMUNITY; LEUKOCYTE; PROSPECTIVE STUDY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UROSEPSIS; AGED; BIOSYNTHESIS; CASE CONTROL STUDY; CELL CULTURE; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; GRAM NEGATIVE INFECTION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PROCEDURES; SEPSIS; UPREGULATION; URINARY TRACT INFECTION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTERLEUKIN-1BETA; LEUKOCYTES; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; URINARY TRACT INFECTIONS;

EID: 84922106198     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000282     Document Type: Article

References (33)

1. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297, 2004.
2. Meister G, Tuschl T: Mechanisms of gene silencing by double-stranded RNA. Nature 431:343-349, 2004.
3. Kloosterman WP, Plasterk RH: The diverse functions of microRNAs in animal development and disease. Dev Cell 11:441-450, 2006.
4. Stefani G, Slack FJ: Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 9:219-230, 2008.
5. Gantier MP, Sadler AJ, William BR: Fine-tuning of the innate immune response by microRNAs. Immunol Cell Biol 85:458-462, 2007.
6. Sonkoly E, Stahle M, Pivarcsi A: MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 18:131-140, 2008.
7. Taganov KD, Boldin MP, Chang KJ, Baltimore D: NF-.B dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Aacd Sci USA 103:12481-12486, 2006.
8. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D: MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 104:1604-1609, 2007.
9. Hsieh CH, Rau CS, Jeng JC, Chen YC, Lu TH, Wu CJ, Wu YC, Tzeng SL, Yang JC: Whole blood-derived microRNA signatures in mice exposed to lipopolysaccharides. J Biomed Sci 19:69, 2012.
10. Schmidt WM, Spiel AO, Jilma B, Wolzt M, Muller M: In vivo profile of the human leukocyte microRNA response to endotoxemia. Biochem Biophys Res Commun 380:437-441, 2009.
11. Cohen J: The immunopathogenesis of sepsis. Nature 420:885-891, 2002.
12. Beutler B: Inferences, questions and possibilities in Toll-like receptor signaling. Nature 430:257-263, 2004.
13. Bryant CE, Spring DR, Gangloff M, Gay NJ: The molecular basis of the host response to lipopolysaccharide. Nat Rev Microbiol 8:8-14, 2010.
14. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303-1310, 2001.
15. Stamm WE, Hooten TM: Management of urinary tract infections in adults. N Engl J Med 329:1328-1334, 1993.
16. Mathes E, O-Dea EL, Hoffmann A, Ghosh G: NF-.B dictates the degradation pathway of I.B!. EMBO J 27:1357-1367, 2008.
17. Ma X, Becker Buscaglia LE, Barker JR, Li Y: MicroRNAs in NF-.B signaling. J Mol Cell Biol 3:159-166, 2011.
18. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA, et al.: Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-! stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179:5082-5089, 2007.
19. Liu Y, Chen Q, Song Y, Lai L, Wang J, Yu H, Cao X, Wang Q: MicroRNA-98 negatively regulates IL-10 production and endotoxin tolerance in macrophages after LPS stimulation. FEBS Lett 585:1963-1968, 2011.
20. Hu G, Zhou R, Liu J, Gong AY, Eischeid AN, Dittman JW, Chen XM: MicroRNA-98 and let-7 confer cholangiocyte expression of cytokine-inducible Src homology 2-containing protein in response to microbial challenge. J Immunol 183:1617-1624, 2009.
21. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655, 1992.
22. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ: MiRBase: tools for microRNA genomics. Nucleic Acids Res 36:D154YD158, 2008.
23. Vorwerk S, Ganter K, Cheng Y, Hoheisel J, Stahler PF, Beier M: Microfluidicbased enzymatic on-chip labeling of miRNAs. N Biotechnol 25:142-149, 2008.
24. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, Nicoloso MS, Barbarotto E, Papa M, Stanciulea O, et al.: MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One 4:e7405, 2009.
25. Yoshimura A, Naka T, Kubo M: SOCS proteins, cytokine signaling and immune regulation. Nat Rev Immunol 7:454-465, 2007.
26. Wang H, Zhang P, Chen W, Feng D, Jia Y, Xie L: Serum microRNA signatures identified by Solexa sequencing predict sepsis patients' mortality: a prospective observational study. PLoS One 4:e38885, 2012.
27. Roerburg C, Luedde M, Vargas Cardenas D, Vucur M, Scholten D, Frey N, Koch A, Trautwein C, Tacke F, Luedde T: Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsis. PLoS One 8:e54612, 2013.
28. Wang H, Meng K, Chen WJ, Feng D, Jia Y, Xie L: Serum miR-574-5p: a prognostic predictor of sepsis patients. Shock 3:263-267, 2012.
29. Wang HJ, Zhang PJ, Chen WJ, Feng D, Jia YH, Xie LX: Four serum microRNAs identified as diagnostic biomarkers of sepsis. J Trauma Acute Care Surg 73:850-854, 2012.
30. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-agadjanyan EL, PetersonA, Noteboom J, O-Briant KC, Allen A, et al.: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:10513-10518, 2008.
31. Pigati L, Yaddanapudi SC, lyengar R, Kim DJ, Hearn SA, Danforth D, Hastings ML, Duelli DM: Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One 5:e13515, 2010.
32. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, Rajewsky N, Bender TP, Rajewsky K: MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131:146-159, 2007.
33. Tano N, Kim HW, Ashraf M: microRNA-150 regulates mobilization and migration of bone marrow-derived mononuclear cells by targeting Cxcr4. PLoS One 6:e231114, 2011.